Celgene

Celgene: EU panel recommends new Revlimid approval
Yahoo/AP
Sat, 04/27/13 - 09:56 am
Celgene
Celgene profit beats estimates as demand for cancer drugs rise
Reuters
Thu, 04/25/13 - 10:48 am
earnings
Celgene
5 Top Biotechs With Bolting Stocks, Earnings On Tap
Investors.com
Tue, 04/23/13 - 11:34 am
earnings
Medicines Company
Celgene
Gilead
Amgen
Biogen Idec
5 Must-Watch Earnings Reports in the Health-Care Sector This Week
Motley Fool
Mon, 04/22/13 - 11:14 am
earnings
Eli Lilly
Wellpoint
Biogen Idec
Celgene
Alexion
5 Stocks Pushing The Drugs Industry Downward
TheStreet.com
Mon, 04/15/13 - 03:11 pm
Celgene
Forest Labs
Alexion
Gilead
Bristol-Myers Squibb
2 Hot Biotech Stocks to Buy Now
Motley Fool
Sun, 04/14/13 - 12:13 pm
Biogen Idec
Celgene
[video]Some Cancers ‘Absolutely’ Curable: Celgene CEO
CNBC
Fri, 04/12/13 - 09:57 am
Celgene
cancer
Pharma CEOs
Is Celgene's Apremilast A Potential Blockbuster Or Not?
Seeking Alpha
Fri, 04/12/13 - 09:48 am
Celgene
apremilast
AbbVie
Amgen
JNJ
Humira
Stelara
psoriasis
Enbrel
Final Four Stocks: Celgene vs. Johnson & Johnson
Motley Fool
Sun, 04/7/13 - 10:57 am
Celgene
JNJ
Astex Pharmaceuticals: A Catalyst-Driven Year Ahead
Seeking Alpha
Fri, 04/5/13 - 11:11 am
Astex
SG-110
Celgene
Can New Psoriasis Drugs Scratch Investors' Itch?
Investors.com
Thu, 04/4/13 - 01:52 pm
investors
psoriasis
Amgen
Eli Lilly
Pfizer
Novartis
Celgene
Humira
AbbVie
Stelara
Remicade
Enbrel
apremilast
brodalumab
Xeljanz
Cyclacel says Celgene will buy 4 patents related to Istodax for $5.5M, resolving lawsuits
Yahoo/AP
Thu, 04/4/13 - 09:25 am
Istodax
Cyclacel
Celgene
patents
Celgene's Rich Pipeline Offers Growth
Seeking Alpha
Thu, 04/4/13 - 09:13 am
Celgene
Eli Lilly
Bristol-Myers Squibb
Roche
ONYX Pharmaceuticals
Pomalyst
Revlimid
Abraxane
Celgene's Star Drug Revlimid And Its Competitors
Seeking Alpha
Sat, 03/30/13 - 10:57 am
Celgene
Revlimid
Multiple Myeloma
JNJ
Velcade
AbbVie
Bristol-Myers Squibb
elotuzumab
Why Celgene's Management Is a Strength
Motley Fool
Sat, 03/23/13 - 08:58 am
Celgene
Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players
Motley Fool
Wed, 03/20/13 - 11:56 am
lung cancer
Roche
Avastin
Tarceva
Astellas
Pfizer
Xalkori
Celgene
Abraxane
Gemzar
Alimta
Eli Lilly
3 Companies Developing Novel Cancer Drug Delivery Platforms
Seeking Alpha
Mon, 03/18/13 - 11:10 am
drug delivery
cancer
Celgene
AngioDynamics
OncoSec
Puma Biotechnology Priced Like Takeover Target: Real M&A
Bloomberg
Tue, 03/12/13 - 11:26 am
Puma Biotechnology
M&A
AstraZeneca
Bristol-Myers Squibb
Takeda
Celgene
GSK
Is Celgene Recession-Resistant?
Wall Street Cheat Street
Sat, 03/9/13 - 11:43 am
Celgene
Amgen And The Biosimilar Threat: Lessons From Affymax
Seeking Alpha
Fri, 03/8/13 - 11:12 am
biosimilars
Amgen
Affymax
AbbVie
Biogen Idec
Celgene
Fresenius
Merck
Gilead

Pages